share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  05/29 10:08
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.
据Vertex Pharmicals Inc.宣布,该公司高管卡门·博齐奇定于2024年5月29日出售2,280股普通股。这些股票的总市值为1,015,876.80美元,由Bozic于2024年10月2日通过限制性股票归属收购,限制性股票归属是发行人的一种补偿。根据提供的交易历史记录,这笔交易是在Bozic在过去三个月中没有出售任何证券的时期之后进行的。
据Vertex Pharmicals Inc.宣布,该公司高管卡门·博齐奇定于2024年5月29日出售2,280股普通股。这些股票的总市值为1,015,876.80美元,由Bozic于2024年10月2日通过限制性股票归属收购,限制性股票归属是发行人的一种补偿。根据提供的交易历史记录,这笔交易是在Bozic在过去三个月中没有出售任何证券的时期之后进行的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息